Lung Cancer Targets and Therapy
Last updated ISSN 1179-2728
Lung Cancer Targets and Therapy is published by Dove Medical Press in medicine. It is open access. The article processing charge is $2,320.
Is your paper a fit?
The surest way to know is to compare your own abstract against what this journal has actually been publishing, rather than against its aims-and-scope page. Paste your abstract and Journal Hunt will tell you how close Lung Cancer Targets and Therapy is — and show you journals like it.
What it publishes
Recent work in Lung Cancer Targets and Therapy concentrates on these topics, taken from its published record rather than from its own description:
- Lung Cancer Treatments and Mutations
- Lung Cancer Research Studies
- Lung Cancer Diagnosis and Treatment
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Cancer Genomics and Diagnostics
- Cancer therapeutics and mechanisms
- HER2/EGFR in Cancer Research
- Cancer-related Molecular Pathways
- Neuroendocrine Tumor Research Advances
Key facts
| Publisher | Dove Medical Press |
|---|---|
| ISSN | 1179-2728 |
| Subject area | Medicine |
| Access | Open access |
| Article processing charge | $2,320 |
| Indexed in | Web of Science — Emerging Sources Citation Index · Scopus · DOAJ |
| Articles published | 217 |
| Publishing since | 2010 |
| Journal website | www.dovepress.com/lung-cancer-targets--therapy-journ |
Facts come from OpenAlex, DOAJ and Wikidata and may lag the journal’s own pages. Check the publisher’s site before submitting. Indexing shown here is what is recorded, not a complete picture — about a third of journals have no indexing recorded anywhere we can read, so “not recorded” does not mean a journal is absent from Scopus or Web of Science.
Journals like Lung Cancer Targets and Therapy
Other established journals in medicine, if this one is not the right home for your paper: